BOSTON BIOPHARMA Trademark

Trademark Overview

On Thursday, February 1, 2018, a trademark application was filed for BOSTON BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the BOSTON BIOPHARMA trademark a serial number of 87780211. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 18, 2020. This trademark is owned by Boston Biopharma, Inc. The BOSTON BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Consultation in the field of pharmaceutical research and development
boston biopharma

General Information

Serial Number87780211
Word MarkBOSTON BIOPHARMA
Filing DateThursday, February 1, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 18, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical research and development; Consultation in the field of pharmaceutical research and development
Pseudo MarkBOSTON BIO PHARMACEUTICAL

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 11, 2018
Primary Code042
First Use Anywhere DateMonday, December 24, 2012
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameBoston Biopharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRoswell, GA 30075

Trademark Events

Event DateEvent Description
Wednesday, November 18, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, November 18, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 7, 2020NON-FINAL ACTION E-MAILED
Thursday, May 7, 2020NON-FINAL ACTION WRITTEN
Thursday, April 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 26, 2019NON-FINAL ACTION E-MAILED
Saturday, October 26, 2019NON-FINAL ACTION WRITTEN
Thursday, April 25, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 25, 2018LETTER OF SUSPENSION E-MAILED
Thursday, October 25, 2018SUSPENSION LETTER WRITTEN
Thursday, May 17, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 17, 2018NON-FINAL ACTION E-MAILED
Thursday, May 17, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Sunday, February 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharma boston pharmaceutical development research field consultation